• Chart
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs
    1. Home
    2. Stocks
    3. Polymed Share Price

    Poly Medicure Share PricePoly Medicure

    Mid Cap 5.5k Result
    ₹1,592.8
    67.15 (4.4%)
    • Advice
    • Hold
    As on 03 December, 2023 | 23:22 BSE: 531768 NSE: POLYMEDISIN: INE205C01021

    Poly Medicure Performance

    Day Range

    • Low 1,530.00
    • High 1,608.00
    ₹ 1,592.8

    52 Week Range

    • Low 820.30
    • High 1,608.00
    ₹ 1,592.8
    • Open Price1,538.60
    • Previous Close1,525.65
    • Volume159007

    Start SIP in Poly Medicure

    Start SIP

    Poly Medicure Share Price

    • Over 1 Month 13.66%
    • Over 3 Month 14.23%
    • Over 6 Month 63.67%
    • Over 1 Year 65.1%

    Poly Medicure Key Statistics

    P/E Ratio 65.4
    PEG Ratio 1
    Market Cap Cr 15,286
    Price to Book Ratio 12.3
    EPS 18.2
    Dividend 0.2
    Relative Strength Index 66.3
    Money Flow Index 71.24
    MACD Signal 32.09
    Average True Range 55.03

    Poly Medicure Investment Rating

    • Master Rating:

    • Poly Medicure has an operating revenue of Rs. 1,249.81 Cr. on a trailing 12-month basis. An annual revenue growth of 20% is outstanding, Pre-tax margin of 21% is great, ROE of 14% is good. The company has a reasonable debt to equity of 1%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 11% and 34% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 1% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 95 which is a GREAT score indicating consistency in earnings, a RS Rating of 75 which is FAIR indicating the recent price performance, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 31 indicates it belongs to a strong industry group of Medical-Systems/Equip and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Poly Medicure Financials
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 320306293272264239244
    Operating Expenses Qtr Cr 237220212203198191188
    Operating Profit Qtr Cr 83858268664857
    Depreciation Qtr Cr 15151514141414
    Interest Qtr Cr 2225011
    Tax Qtr Cr 1920161716913
    Net Profit Qtr Cr 59615748452938
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 1,104918
    Operating Expenses Annual Cr 804667
    Operating Profit Annual in Cr 264212
    Depreciation Cr 5653
    Interest Annual Cr 84
    Tax Annual Cr 5849
    Net Profit Annual Cr 179146
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 195126
    Cash from Investing Activity Annual Cr -187-89
    Cash from Financing Annual Activity Cr -8-40
    Net Cash Flow Annual Cr 0-2
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 1,2341,077
    Fixed Assets Annual Cr 676494
    Total Non Current Assets Annual Cr 782593
    Total Current Assets Annual Cr 756741
    Total Assets Annual Cr 1,5381,334
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 129112
    ROE Annual % 1514
    ROCE Annual % 1918
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 2829
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 337321307285275249258
    Operating Expenses Qtr Cr 253234224214210202202
    Operating Profit Qtr Cr 84878371654656
    Depreciation Qtr Cr 16161514141414
    Interest Qtr Cr 2225011
    Tax Qtr Cr 1920161716913
    Net Profit Qtr Cr 62635950432736
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 1,151961
    Operating Expenses Annual Cr 850710
    Operating Profit Annual in Cr 265213
    Depreciation Cr 5754
    Interest Annual Cr 94
    Tax Annual Cr 5849
    Net Profit Annual Cr 179147
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 191123
    Cash from Investing Activity Annual Cr -179-85
    Cash from Financing Annual Activity Cr -13-35
    Net Cash Flow Annual Cr -13
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 1,2421,087
    Fixed Assets Annual Cr 685503
    Total Non Current Assets Annual Cr 770593
    Total Current Assets Annual Cr 807783
    Total Assets Annual Cr 1,5771,377
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 129113
    ROE Annual % 1413
    ROCE Annual % 1917
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 2727
    Invest in Poly Medicure

    Poly Medicure Technicals

    EMA & SMA

    Current Price
    ₹1,592.8
    67.15 (4.4%)
    pointer
    • Bullish Moving Average
    • ___
    • 16
    • Bearish Moving Average
    • ___
    • 0
    • 20 Day
    • ₹1,493.71
    • 50 Day
    • ₹1,439.44
    • 100 Day
    • ₹1,360.66
    • 200 Day
    • ₹1,234.70
    • 20 Day
    • ₹1,487.60
    • 50 Day
    • ₹1,427.30
    • 100 Day
    • ₹1,372.20
    • 200 Day
    • ₹1,180.55

    Poly Medicure Resistance and Support

    PIVOT
    ₹1,576.94
    Resistance
    First Resistance 1,623.87
    Second Resistance 1,654.93
    Third Resistance 1,701.87
    RSI 66.30
    MFI 71.24
    MACD Single Line 32.09
    MACD 36.67
    Support
    First Resistance 1,545.87
    Second Resistance 1,498.93
    Third Resistance 1,467.87

    Poly Medicure Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 173,499 7,214,088 41.58
    Week 98,609 4,349,654 44.11
    1 Month 125,855 4,693,149 37.29
    6 Month 188,783 6,024,055 31.91

    Poly Medicure Result Highlights

    Poly Medicure Synopsis

    NSE-Medical-Systems/Equip

    Poly Medicure Lt is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company’s Total Operating Revenue is Rs. 1068.05 Cr. and Equity Capital is Rs. 47.97 Cr. for the Year ended 31/03/2023. Poly Medicure Ltd. is a Public Limited Listed company incorporated on 30/03/1995 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L40300DL1995PLC066923 and registration number is 066923.
    Market Cap 15,286
    Sales 1,191
    Shares in Float 4.51
    No of funds 127
    Yield 0.19
    Book Value 12.38
    U/D Vol ratio 1.1
    LTDebt / Equity 1
    Alpha 0.2
    Beta 0.46

    Poly Medicure

    Owner NameSep-23Jun-23Mar-23Dec-22
    Promoters 53.16%53.31%53.31%53.33%
    Mutual Funds 3.95%3.27%3.02%3.01%
    Insurance Companies 0.99%0.78%0.45%0.18%
    Foreign Portfolio Investors 14.49%15.61%16.21%16.33%
    Individual Investors 11.35%11.1%11.11%11.18%
    Others 16.06%15.93%15.9%15.97%

    Poly Medicure Management

    Name Designation
    Mr. Devendra Raj Mehta Chairman
    Mr. Himanshu Baid Managing Director
    Mr. Rishi Baid Joint Managing Director
    Mr. Jugal Kishore Baid Non Executive Director
    Mrs. Mukulika Baid Non Executive Director
    Mr. Alessandro Balboni Non Executive Director
    Dr. Sandeep Bhargava Ind. Non-Executive Director
    Mr. Amit Khosla Ind. Non-Executive Director
    Ms. Sonal Mattoo Ind. Non-Executive Director
    Mr. Prakash Chand Surana Ind. Non-Executive Director
    Dr. Shailendra Raj Mehta Ind. Non-Executive Director
    Dr. Ambrish Mithal Additional Director

    Poly Medicure Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Poly Medicure Corporate Action

    Date Purpose Remarks
    2023-11-04 Quarterly Results
    2023-08-07 Quarterly Results
    2023-05-09 Audited Results & Final Dividend
    2023-01-28 Quarterly Results
    2022-11-04 Quarterly Results

    Poly Medicure MF Shareholding

    Name Amount(cr)
    UTI Flexi Cap Fund Regular Plan Growth 24,370
    Quant Small Cap Fund Growth 9,521
    UTI Unit Linked Insurance 5,185
    WhiteOak Capital Flexi Cap Fund Regular Growth 2,375
    Bank of India Tax Advantage Fund Regular Growth 860

    Poly Medicure FAQs

    What is Share Price of Poly Medicure ?

    Poly Medicure share price is ₹1,592 As on 03 December, 2023 | 23:08

    What is the Market Cap of Poly Medicure ?

    The Market Cap of Poly Medicure is ₹15286.2 Cr As on 03 December, 2023 | 23:08

    What is the P/E ratio of Poly Medicure ?

    The P/E ratio of Poly Medicure is 65.4 As on 03 December, 2023 | 23:08

    What is the PB ratio of Poly Medicure ?

    The PB ratio of Poly Medicure is 12.3 As on 03 December, 2023 | 23:08

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support desk helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
    ©2023, 5Paisa Capital Ltd. All Rights Reserved.
    We are ISO 27001:2013 Certified.